My Companies
Notification
Account
Log Out
Login
Natco received US FDA tentative approval for Olaparib tablets (100mg, 150mg), a generic of Lynparza, with estimated US sales of $1.4B. Partner Alembic will distribute. Para IV litigation is ongoing.
Natco Pharma Explores ₹2,000 Crore Capital Raise Alongside Q1 Results
Natco Pharma Board Approves ₹1,069 Crore Adcock Ingram Stake Hike To 49%